These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 538037)

  • 1. Analysis of factors influencing antibiotic usage in hospitals.
    Sabath LD; Notto DA
    Prog Clin Biol Res; 1979; 35():65-74. PubMed ID: 538037
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug cost containment in the hospital.
    Smith WE
    Hosp Formul; 1978 Sep; 13(9):695-8. PubMed ID: 10238490
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlling the costs of antibiotic resistance.
    North D
    Clin Ther; 1993; 15 Suppl A():3-11. PubMed ID: 8513459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antibiotic utilization committee.
    Zeman BT; Pike M; Samet C
    Hospitals; 1974 Apr; 48(8):73-6. PubMed ID: 4820315
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacy U.R. cuts costs, drug use.
    Mosier RL
    Hosp Peer Rev; 1979 May; 4(5):70-2. PubMed ID: 10308905
    [No Abstract]   [Full Text] [Related]  

  • 6. P&T Committee antibiotic cost considerations.
    Rinehart JR
    Hosp Formul; 1986 Aug; 21(8):857-9, 862-4. PubMed ID: 10277580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods of controlling cephalosporin use in Canadian hospitals.
    Godin JP; Sketris IS; Merrett RA; Marrie TJ
    Can J Hosp Pharm; 1988 Apr; 41(2):73-4, 83-4, 96. PubMed ID: 10287052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replies to the question: should the practice of drug sampling be retained or eliminated?
    Hosp Formul; 1994 Oct; 29(10):720-2. PubMed ID: 10137849
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacy: computerless drug use review.
    Deliganis SG; Johnson SR
    Hospitals; 1973 Dec; 47(23):86 passim. PubMed ID: 4761628
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of antibiotic-resistant bacteria: memorandum from a WHO meeting. World Health Organization Scientific Working Group on Antimicrobial Resistance.
    Am J Hosp Pharm; 1984 Jul; 41(7):1329-37. PubMed ID: 6540519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How pharmaceutical controls worked in one Ontario hospital.
    McLean WM; Tierney MG
    Can J Hosp Pharm; 1994 Aug; 47(4):176-9. PubMed ID: 10136951
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceuticals in Australia: priorities in a teaching hospital.
    Kearney BJ
    Physician Exec; 1993; 19(5):63-7. PubMed ID: 10130953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The limitation of antibiotic use in hospitals.
    Williams JD
    Prog Clin Biol Res; 1979; 35():1-7. PubMed ID: 538023
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacy management strategies for responding to hospital reimbursement changes.
    Curtiss FR
    Am J Hosp Pharm; 1983 Sep; 40(9):1489-92. PubMed ID: 6353913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotics policy in Spanish hospitals: the role of the infections consultant in its optimization].
    Gómez J
    Med Clin (Barc); 1997 Sep; 109(8):300-1. PubMed ID: 9379753
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacoeconomic considerations in rural hospitals.
    Lenhert P
    Cost Qual Q J; 1998 Jun; 4(2):37-42. PubMed ID: 10182598
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of a hospital antibiotic policy in England.
    Selwyn S
    Prog Clin Biol Res; 1979; 35():155-60. PubMed ID: 538030
    [No Abstract]   [Full Text] [Related]  

  • 18. Some legal aspects of the hospital formulary system.
    Fink JL
    Am J Hosp Pharm; 1974 Jan; 31(1):86-90. PubMed ID: 4589389
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is it possible to rationalize antibiotic usage in hospitals?].
    Ribas J; Trilla A
    Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):577-80. PubMed ID: 8808472
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost savings achieved through cephalosporin use review and restriction.
    Dzierba SH; Reilly RT; Caselnova DA
    Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.